Shuttle Pharmaceuticals Ownership 2024 | Who Owns Shuttle Pharmaceuticals Now?
Institutional Ownership
0.52%
Insider Ownership
45.80%
Retail Ownership
53.68%
Institutional Holders
6.00
Shuttle Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TWO SIGMA SECURITIES, LLC | 0.26% | 0.00% | 42,288 | 42,288 | 100.00% | 16,907 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.19% | - | 30,823 | -6,134 | -16.60% | 12,297 | Jun 30, 2024 |
VIRTU FINANCIAL LLC | 0.08% | 0.00% | 12,744 | 2,266 | 21.63% | 5,000 | Jun 30, 2024 |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.00% | - | 500 | - | - | 200 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | - | 431 | 180 | 71.71% | 172 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 56 | 56 | 100.00% | 22 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -54 | -100.00% | - | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -16,500 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -1,121 | -100.00% | - | Jun 30, 2024 |
Shuttle Pharmaceuticals's largest institutional shareholder is TWO SIGMA SECURITIES, LLC, holding 0.26% of the company's total share outstanding, currently valued at $16.91K. The top 10 institutional shareholders own together 0.52% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VIRTU FINANCIAL LLC | 0.08% | 0.00% | 12,744 | 2,266 | 21.63% | 5,000 | Jun 30, 2024 |
TWO SIGMA SECURITIES, LLC | 0.26% | 0.00% | 42,288 | 42,288 | 100.00% | 16,907 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | - | 431 | 180 | 71.71% | 172 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.19% | - | 30,823 | -6,134 | -16.60% | 12,297 | Jun 30, 2024 |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.00% | - | 500 | - | - | 200 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 56 | 56 | 100.00% | 22 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -54 | -100.00% | - | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -16,500 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -1,121 | -100.00% | - | Jun 30, 2024 |
The largest Shuttle Pharmaceuticals shareholder by % of total assets is VIRTU FINANCIAL LLC. The company owns 12.74K shares of Shuttle Pharmaceuticals (SHPH), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TWO SIGMA SECURITIES, LLC | 0.26% | 0.00% | 42,288 | 42,288 | 100.00% | 16,907 | Jun 30, 2024 |
VIRTU FINANCIAL LLC | 0.08% | 0.00% | 12,744 | 2,266 | 21.63% | 5,000 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | - | 431 | 180 | 71.71% | 172 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 56 | 56 | 100.00% | 22 | Jun 30, 2024 |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.00% | - | 500 | - | - | 200 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -54 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -1,121 | -100.00% | - | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.19% | - | 30,823 | -6,134 | -16.60% | 12,297 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -16,500 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Shuttle Pharmaceuticals's largest institutional buyer is TWO SIGMA SECURITIES, LLC. The company purchased 42.29K stocks of SHPH, valued at $16.91K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -16,500 | -100.00% | - | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.19% | - | 30,823 | -6,134 | -16.60% | 12,297 | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -1,121 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -54 | -100.00% | - | Jun 30, 2024 |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.00% | - | 500 | - | - | 200 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 56 | 56 | 100.00% | 22 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | - | 431 | 180 | 71.71% | 172 | Jun 30, 2024 |
VIRTU FINANCIAL LLC | 0.08% | 0.00% | 12,744 | 2,266 | 21.63% | 5,000 | Jun 30, 2024 |
TWO SIGMA SECURITIES, LLC | 0.26% | 0.00% | 42,288 | 42,288 | 100.00% | 16,907 | Jun 30, 2024 |
As of Jun 30 2024, Shuttle Pharmaceuticals's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -16.50K shares of SHPH, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TWO SIGMA SECURITIES, LLC | 0.26% | 0.00% | 42,288 | 42,288 | 100.00% | 16,907 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 56 | 56 | 100.00% | 22 | Jun 30, 2024 |
Shuttle Pharmaceuticals's largest new institutional shareholder by number of shares is TWO SIGMA SECURITIES, LLC, purchased 42.29K shares, valued at $16.91K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -16,500 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -1,121 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -54 | -100.00% | - | Jun 30, 2024 |
Shuttle Pharmaceuticals's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -16.50K shares, valued at -, as of undefined.
Shuttle Pharmaceuticals Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.00% | 36,957 | - | - | Feb 29, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 572 | - | - | Jan 31, 2024 |
BLACKROCK FUNDS | 0.00% | 4,125 | - | - | Mar 28, 2024 |
Shuttle Pharmaceuticals's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 36.96K shares, compromising 0.00% of its total assets.
Shuttle Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 6 | -14.29% |
31 Mar, 24 | 7 | 16.67% |
31 Dec, 23 | 6 | 50.00% |
30 Sep, 23 | 4 | 300.00% |
30 Jun, 23 | 1 | -50.00% |
31 Mar, 23 | 2 | -75.00% |
31 Dec, 22 | 8 | -11.11% |
30 Sep, 22 | 9 | - |
As of 30 Jun 24, 6 institutions are holding Shuttle Pharmaceuticals's shares, representing a decrease of -14.29% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 86,842 | 31.86% |
31 Mar, 24 | 65,861 | -51.48% |
31 Dec, 23 | 135,747 | -47.29% |
30 Sep, 23 | 257,532 | 2.64% |
30 Jun, 23 | 250,915 | 608.32% |
31 Mar, 23 | 35,424 | -73.48% |
31 Dec, 22 | 133,596 | -73.49% |
30 Sep, 22 | 503,901 | - |
Shuttle Pharmaceuticals (SHPH) has 86.84K shares outstanding as of 30 Jun 24, up 31.86% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 0.52% | 268.92% |
31 Mar, 24 | 0.44% | 59.38% |
31 Dec, 23 | 0.86% | 26.44% |
30 Sep, 23 | 1.81% | 53.33% |
30 Jun, 23 | 1.84% | 2726.40% |
31 Mar, 23 | 0.26% | 15.60% |
31 Dec, 22 | 1.29% | 5.25% |
30 Sep, 22 | 4.96% | - |
As of 30 Jun 24, Shuttle Pharmaceuticals is held by 0.52% institutional shareholders, representing a 268.92% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 4 | - |
31 Mar, 24 | 4 | - |
31 Dec, 23 | 4 | 33.33% |
30 Sep, 23 | 3 | 200.00% |
30 Jun, 23 | 1 | - |
31 Mar, 23 | - | -100.00% |
31 Dec, 22 | 3 | -66.67% |
30 Sep, 22 | 9 | - |
4 institutional shareholders have increased their position in SHPH stock as of 30 Jun 24 compared to 4 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | 1 | -50.00% |
31 Mar, 24 | 2 | 100.00% |
31 Dec, 23 | 1 | - |
30 Sep, 23 | 1 | - |
30 Jun, 23 | - | -100.00% |
31 Mar, 23 | 2 | -50.00% |
31 Dec, 22 | 4 | - |
30 Sep, 22 | - | - |
1 institutional shareholders have reduced their position in SHPH stock as of 30 Jun 24 compared to 2 in the previous quarter (a -50.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 6 | -14.29% | 86,842 | 31.86% | 0.52% | 268.92% | 4 | - | 1 | -50.00% |
31 Mar, 24 | 7 | 16.67% | 65,861 | -51.48% | 0.44% | 59.38% | 4 | - | 2 | 100.00% |
31 Dec, 23 | 6 | 50.00% | 135,747 | -47.29% | 0.86% | 26.44% | 4 | 33.33% | 1 | - |
30 Sep, 23 | 4 | 300.00% | 257,532 | 2.64% | 1.81% | 53.33% | 3 | 200.00% | 1 | - |
30 Jun, 23 | 1 | -50.00% | 250,915 | 608.32% | 1.84% | 2726.40% | 1 | - | - | -100.00% |
31 Mar, 23 | 2 | -75.00% | 35,424 | -73.48% | 0.26% | 15.60% | - | -100.00% | 2 | -50.00% |
31 Dec, 22 | 8 | -11.11% | 133,596 | -73.49% | 1.29% | 5.25% | 3 | -66.67% | 4 | - |
30 Sep, 22 | 9 | - | 503,901 | - | 4.96% | - | 9 | - | - | - |
Shuttle Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Shuttle Pharmaceuticals's stock was made by Lorber Timothy J. on Jun 25 2024, selling - shares at - per share (valued at -).
Shuttle Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 1 | - | - |
Q4 2023 | - | 2 | - |
Q3 2023 | 1 | 1 | 100.00% |
Q1 2023 | 1 | - | - |
Q4 2022 | - | 10 | - |
Q3 2022 | 1 | 11 | 9.09% |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Shuttle Pharmaceuticals's insiders, as of Q1 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | - | - | - |
Q4 2023 | - | 2 | - |
Q3 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | 9 | - |
Q3 2022 | - | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Shuttle Pharmaceuticals's stocks.
SHPH Ownership FAQ
Who Owns Shuttle Pharmaceuticals?
Shuttle Pharmaceuticals is owned by institutional shareholders (0.52%), insiders (45.80%), and public (53.68%). The largest institutional shareholder of Shuttle Pharmaceuticals is TWO SIGMA SECURITIES, LLC (0.26% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of Shuttle Pharmaceuticals?
Shuttle Pharmaceuticals's major institutional shareholders are TWO SIGMA SECURITIES, LLC, GEODE CAPITAL MANAGEMENT, LLC, VIRTU FINANCIAL LLC, FEDERATION DES CAISSES DESJARDINS DU QUEBEC, and TOWER RESEARCH CAPITAL LLC (TRC). The top five shareholders own together 0.52% of the company's share outstanding.
How many Shuttle Pharmaceuticals shareholders are there?
As of Jun 2024, there are 6 institutional shareholders of Shuttle Pharmaceuticals.
What percentage of Shuttle Pharmaceuticals is owned by TWO SIGMA SECURITIES, LLC?
TWO SIGMA SECURITIES, LLC owns 42.29K shares of Shuttle Pharmaceuticals, representing 0.26% of the company's total shares outstanding, valued at $16.91K (as of Jun 2024).
What percentage of Shuttle Pharmaceuticals is owned by GEODE CAPITAL MANAGEMENT, LLC?
As of Jun 2024, GEODE CAPITAL MANAGEMENT, LLC holds 30.82K shares of Shuttle Pharmaceuticals (SHPH), compromising 0.19% of the company, valued at $12.3K.
What percentage of Shuttle Pharmaceuticals is owned by VIRTU FINANCIAL LLC?
VIRTU FINANCIAL LLC is the third largest holder of Shuttle Pharmaceuticals. The company owns 12.74K of the company's shares outstanding (worth $5K).